Mural Oncology plc Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2022 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Mural Oncology plc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2022 to Q2 2025.
  • Mural Oncology plc Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2025 was $4.36M, a 56.9% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2025 $4.36M -$5.77M -56.9% Jun 30, 2025 10-Q 2025-08-04
Q1 2025 $5.58M -$5.84M -51.2% Mar 31, 2025 10-Q 2025-05-14
Q4 2024 $6.78M -$5.96M -46.8% Dec 31, 2024 10-Q 2025-08-04
Q3 2024 $8.63M -$5.52M -39% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $10.1M Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $11.4M Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $12.7M -$5.57M -30.4% Dec 31, 2023 10-K 2025-03-11
Q3 2023 $14.2M Sep 30, 2023 10-Q 2023-12-14
Q4 2022 $18.3M Dec 31, 2022 10-K 2024-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.